Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore which Low Cost Dividend ETF to invest in right now. We compare costs, yields, and diversification to help you decide efficiently.
27,336 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
If Spirit faces liquidation, the fleet faces a multi-step journey from repossession to resale. Here's a concise brief...
April data show a split in new construction: multifamily projects surged while single-family starts declined, leaving...
A powerful wave of industry consolidation in 2026 is reshaping energy markets, elevating takeover risk for select sma...
A new Ethereum governance proposal would allow validators to vote on diverting up to 10% of staking rewards to ecosys...
U.S. retirees are eyeing Panama’s beach towns as costs rise at home. The question remains: can $600,000 sustain a rel...
Bitcoin and Ethereum hold firm as stablecoins drop more than $10B since May, signaling a shift toward memecoins. Regu...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
A new Ripple survey shows banks leaning into digital assets, with stablecoins leading cash-flow efficiency. For XRP, ...
European Union and United States trade talks accelerate, threatening tariff changes that could ripple through inflati...
A high-stakes dispute between MRED and Zillow has led to tens of thousands of Chicago listings being pulled from Zill...